FDA Approves First Oral Weight Loss Pill
Business & Finance News Today | 2 Min News | The Daily News Now! · The Daily News Now!
Audio is streamed directly from the publisher (api.fastcast.ai) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
FDA approves Eli Lillys Foundayo, the first oral GLP-one weight loss pill, available as a once-daily tablet. Trial data shows significant weight loss, with the top dose resulting in an average of 27.3 pounds lost over 72 weeks. Foundayo competes with Novo Nordisks Wegovy, with forecasts predicting $14.79 billion in annual revenue within five years. Side effects include common issues like nausea and headaches, as well as thyroid tumor warnings.
Support the show:
Get a discount at https://solipillow.com/discount/dnn.
Advertise on DNN:
[email protected]
This is an automated, high-level news summary based on public reporting.
Report issues to [email protected].
View sources & latest updates:
https://sources.thednn.ai/5ede05593320835c